The role of B-1 lymphocytes in antitumor immunity in patients with gastric cancer
- Authors: Chulkova S.V.1,2, Sholokhova E.N.1, Grishchenko N.V.1, Ryabchikov D.A.1, Grivtsova L.Y.3, Bazin I.S.1, Tupitsyn N.N.1
-
Affiliations:
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
- Pirogov Russian National Research Medical University
- A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 4 (2018)
- Pages: 64-70
- Section: ORIGINAL REPORTS
- Published: 11.12.2018
- URL: https://bioterapevt.abvpress.ru/jour/article/view/1128
- DOI: https://doi.org/10.17650/1726-9784-2018-17-4-64-70
- ID: 1128
Cite item
Full Text
Abstract
Introduction. B1-lymphocytes are a subpopulation of B-cells, the proportion of which in the spleen accounts for 5 % of the total number of B-cells. B1-lymphocytes predominantly secrete IgM, which plays an important role in the induction of tumor cell apoptosis. Splenec tomy for the purpose of adequate lymph node dissection in gastric cancer causes marked and prolonged immunological disorders. It primarily affects the B1a-lymphocyte subpopulation, which provides a thymus-independent immune response.
Objective. To study the features of the B-cell component of immunity in patients with gastric cancer.
Materials and methods. The subpopulation composition of B-lymphocytes of peripheral blood of gastric cancer patients undergoing sur gical treatment using flow cytometry (Facs Can, Lysys II and FacsCanto II programs, Facs Diva program) was analyzed. Cells were stained simultaneously with three monoclonal antibodies labeled with different fluorochromes.
Results. The data obtained demonstrate a violation of the composition of B-cell subpopulations. In the group of patients with standard D2 lymph node dissection and splenectomy at the preoperative stage and three months after surgery, a significant correlation was found between the relative number of B lymphocytes (p = 0.018), CD5 + B lymphocytes (p = 0.012) and the number of CD19 + CD38 + cells (p = 0.035). In addition, after surgical treatment, the percentage of CD5 + B-lymphocytes increased significantly from 12.9 to 21.8 %, while the total number of CD19 + lymphocytes and CD19 + CD21 + cells decreased.
Conclusion. In patients of the experimental group, a decrease in antibody production, weakening of both general and antitumor immunity can be observed.About the authors
S. V. Chulkova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Pirogov Russian National Research Medical University
Author for correspondence.
Email: chulkova@mail.ru
ORCID iD: 0000-0003-4412-5019
24 Kashirskoe Shosse, Moscow 115478,
1 Ostrovitianov St., Moscow 117997
Russian FederationE. N. Sholokhova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia24 Kashirskoe Shosse, Moscow 115478 Russian Federation
N. V. Grishchenko
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
ORCID iD: 0000-0002-7515-8182
24 Kashirskoe Shosse, Moscow 115478 Russian Federation
D. A. Ryabchikov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia24 Kashirskoe Shosse, Moscow 115478 Russian Federation
L. Y. Grivtsova
A. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center of the Ministry of Health of the Russian Federation10 Marshal Zhukov St., Obninsk, Kaluga region, 249031 Russian Federation
I. S. Bazin
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia24 Kashirskoe Shosse, Moscow 115478 Russian Federation
N. N. Tupitsyn
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
ORCID iD: 0000-0003-3966-128X
24 Kashirskoe Shosse, Moscow 115478 Russian Federation
References
Supplementary files

